Cellebrite DI (CLBT) Receivables (2020 - 2025)

Cellebrite DI's Receivables history runs 6 years deep, the most recent figure standing at $183.5 million for Q4 2025.

• On a quarterly basis, Receivables rose 123.18% year-over-year to $183.5 million in Q4 2025; TTM through Dec 2025 was $183.5 million, a 123.18% increase from a year earlier, with the FY2025 full-year figure at $183.5 million, up 12.12% from the prior year.
• Receivables rose to $183.5 million in Q4 2025 per CLBT's latest filing, from $104.2 million in the prior quarter.
• Across five years, Receivables topped out at $183.5 million in Q4 2025 and bottomed at $4.6 million in Q3 2021.
• The 5-year median for Receivables is $81.9 million (2022), against an average of $87.2 million.
• Biggest YoY gain for Receivables was 1841.29% in 2022; the steepest drop was 41.58% in 2022.
• Year by year, Receivables stood at $139.8 million in 2021, then tumbled by 41.58% to $81.6 million in 2022, then increased by 9.64% to $89.5 million in 2023, then retreated by 8.13% to $82.2 million in 2024, then jumped by 123.18% to $183.5 million in 2025.
• Per Business Quant, the three latest CLBT Receivables figures stand at $183.5 million (Q4 2025), $104.2 million (Q3 2025), and $93.1 million (Q2 2025).